Brown Capital Management LLC Bristol Myers Squibb CO Transaction History

Brown Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $195,321 - $234,208	3,177 New	3,177 $232,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $235,650 - $274,712	-4,394 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $291,392 - $423,460	-6,280 Reduced 58.83%	4,394 $245,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $525,267 - $685,164	10,674 New	10,674 $685,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Brown Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Capital Management LLC with notifications on news.